Two Sigma Investments’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-81,605
Closed -$4.45M 3344
2023
Q1
$4.45M Buy
81,605
+8,395
+11% +$490K 0.01% 967
2022
Q4
$4.58M Sell
73,210
-65,985
-47% -$4.38M 0.01% 897
2022
Q3
$9.8M Buy
+139,195
New +$9.6M 0.03% 493
2022
Q2
Sell
-5,899
Closed -$369K 3037
2022
Q1
$369K Sell
5,899
-40,495
-87% -$2.18M ﹤0.01% 2145
2021
Q4
$2.6M Buy
+46,394
New +$2.84M 0.01% 1693
2021
Q3
Sell
-48,478
Closed -$3.31M 4836
2021
Q2
$3.07M Sell
48,478
-34,041
-41% -$2.01M 0.01% 1537
2021
Q1
$4.94M Buy
+82,519
New +$4.49M 0.01% 1052
2019
Q4
Sell
-47,034
Closed -$1.27M 4053
2019
Q3
$1.27M Buy
+47,034
New +$1.64M ﹤0.01% 1792

Other funds holding AXNX

Two Sigma Investments's AXNX Position: Q2 2023 in Review

Two Sigma Investments sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 81,605 shares — an estimated $4.45M sold.

Two Sigma Investments first reported a position in AXNX in Q3 2019 and held it in 8 quarters. The position peaked at $9.8M in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

  • Two Sigma Investments reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 81,605 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $4.45M.
  • Two Sigma Investments first reported a position in Axonics, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
  • Two Sigma Investments's Axonics, Inc. Common Stock position peaked at $9.8M in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.